Abundance of Aβ5-x like immunoreactivity in transgenic 5XFAD, APP/PS1KI and 3xTG mice, sporadic and familial Alzheimer's disease

Molecular Neurodegeneration

Volumn 9, Issue 1, 2014, Pages

  Guzmán, Erika Avendaño ^a   Bouter, Yvonne ^a   Richard, Bernhard C ^a   Lannfelt, Lars ^b   Ingelsson, Martin ^b   Paetau, Anders ^c   Verkkoniemi Ahola, Auli ^c   Wirths, Oliver ^a   Bayer, Thomas A ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UPPSALA UNIVERSITY   (Sweden)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

3xTG; 5XFAD; Amyloid plaques; APP PS1KI; N truncated A ; Vascular deposits

Indexed keywords

AMYLOID BETA 5X PROTEIN; AMYLOID BETA PROTEIN; PRESENILIN 1; UNCLASSIFIED DRUG;

3XTG MOUSE; 5XFAD MOUSE; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROPHORESIS; FAMILIAL ALZHEIMER DISEASE; FAMILIAL DISEASE; GENE MUTATION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOUSE; NERVE DEGENERATION; NONHUMAN; SPORADIC ALZHEIMER DISEASE; VASCULAR AMYLOIDOSIS; WESTERN BLOTTING;

MUS; MUS MUSCULUS;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BLOTTING, WESTERN; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, TRANSGENIC; PRESENILIN-1; TAU PROTEINS;

EID: 84898546230     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-9-13     Document Type: Article

References (55)

1. Classification and basic pathology of Alzheimer disease. Duyckaerts C, Delatour B, Potier MC, Acta Neuropathol 2009 118 5 36 10.1007/s00401-009-0532-1 19381658
2. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Hardy J, Selkoe DJ, Science 2002 297 353 356 10.1126/science.1072994 12130773 (Pubitemid 34790756)
3. The amyloid hypothesis for Alzheimer's disease: a critical reappraisal. Hardy J, J Neurochem 2009 110 1129 1134 10.1111/j.1471-4159.2009.06181.x 19457065
4. Role of Apoe/Abeta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy. Holtzman DM, J Mol Neurosci 2001 17 147 155 10.1385/JMN:17:2:147 11816788 (Pubitemid 33063519)
5. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Karran E, Mercken M, Strooper BD, Nat Rev Drug Discov 2011 10 698 712 10.1038/nrd3505 21852788
6. Gamma-secretase: structure, function, and modulation for Alzheimer's disease. Wolfe MS, Curr Top Med Chem 2008 8 2 8 10.2174/156802608783334024 18220927 (Pubitemid 351791041)
7. The genetics of Alzheimer disease. Tanzi RE, Cold Spring Harbor Perspectives in Medicine 2012 doi:1101/cshperspect.a006296.
8. The toxic a[beta] oligomer and Alzheimer's disease: an emperor in need of clothes. Benilova I, Karran E, De Strooper B, Nat Neurosci 2012 29 349 357
9. Alzheimer's disease. Blennow K, de Leon MJ, Zetterberg H, Lancet 2006 368 387 403 10.1016/S0140-6736(06)69113-7 16876668 (Pubitemid 44108123)
10. APP mutations in the Abeta coding region are associated with abundant cerebral deposition of Abeta 38. Moro ML, Giaccone G, Lombardi R, Indaco A, Uggetti A, Morbin M, Saccucci S, Di Fede G, Catania M, Walsh DM, Demarchi A, Rozemuller A, Bogdanovic N, Bugiani O, Ghetti B, Tagliavini F, Acta Neuropathol 2012 124 809 821 10.1007/s00401-012-1061-x 23143229
11. Abeta38 in the brains of patients with sporadic and familial Alzheimer's disease and transgenic mouse models. Reinert J, Martens H, Huettenrauch M, Kolbow T, Lannfelt L, Ingelsson M, Paetau A, Verkkoniemi-Ahola A, Bayer TA, Wirths O, J Alzheimers Dis 2014 39 871 881 24305500
12. P otent amyloidogenicity and pathogenicity of Abeta 43. Saito T, Suemoto T, Brouwers N, Sleegers K, Funamoto S, Mihira N, Matsuba Y, Yamada K, Nilsson P, Takano J, Nishimura M, Iwata N, Van Broeckhoven C, Ihara Y, Saido TC, Nat Neurosci 2011 14 1023 1032 10.1038/nn.2858 21725313
13. Pyroglutamate Abeta-a hatchet man in Alzheimer disease. Jawhar S, Wirths O, Bayer TA, J Biol Chem 2011 286 38825 38832 10.1074/jbc.R111.288308 21965666
14. A novel monoclonal antibody specific for the amino-truncated beta-amyloid Abeta 5 -40/42 produced from caspase-cleaved amyloid precursor protein. Murayama KS, Kametani F, Tabira T, Araki W, J Neurosci Methods 2007 161 244 249 10.1016/j.jneumeth.2006.11.010 17207535 (Pubitemid 46466952)
15. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, Lannfelt L, Nat Genet 1992 1 345 347 10.1038/ng0892-345 1302033
16. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation. Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron MM, Axelman K, Forsell C, Stenh C, Luthman J, Teplow DB, Younkin SG, Naslund J, Lannfelt L, Nat Neurosci 2001 4 887 893 10.1038/nn0901-887 11528419 (Pubitemid 32801591)
17. Clinical and neuropathological features of the arctic APP gene mutation causing early-onset Alzheimer disease. Basun H, Bogdanovic N, Ingelsson M, Almkvist O, Naslund J, Axelman K, Bird TD, Nochlin D, Schellenberg GD, Wahlund LO, Lannfelt L, Arch Neurol 2008 65 499 505 10.1001/archneur.65.4.499 18413473 (Pubitemid 351549959)
18. A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Crook R, Verkkoniemi A, Perez-Tur J, Mehta N, Baker M, Houlden H, Farrer M, Hutton M, Lincoln S, Hardy J, Gwinn K, Somer M, Paetau A, Kalimo H, Ylikoski R, Poyhonen M, Kucera S, Haltia M, Nat Med 1998 4 452 455 10.1038/nm0498-452 9546792 (Pubitemid 28212762)
19. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM, Neuron 2003 39 409 421 10.1016/S0896-6273(03)00434-3 12895417 (Pubitemid 36937044)
20. Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta 42 accumulation in a novel Alzheimer transgenic model. Casas C, Sergeant N, Itier JM, Blanchard V, Wirths O, van der Kolk N, Vingtdeux V, van de Steeg E, Ret G, Canton T, Drobecq H, Clark A, Bonici B, Delacourte A, Benavides J, Schmitz C, Tremp G, Bayer TA, Benoit P, Pradier L, Am J Pathol 2004 165 1289 1300 10.1016/S0002-9440(10)63388-3 15466394 (Pubitemid 39297734)
21. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, Berry R, Vassar R, J Neurosci 2006 26 10129 10140 10.1523/JNEUROSCI.1202-06.2006 17021169 (Pubitemid 44527407)
22. Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Abeta aggregation in the 5XFAD mouse model of Alzheimer's disease. Jawhar S, Trawicka A, Jenneckens C, Bayer TA, Wirths O, Neurobiol Aging 2012 33 196 e129 -196.e140
23. N-truncated amyloid beta (Abeta) 4-42 forms stable aggregates and induces acute and long-lasting behavioral deficits. Bouter Y, Dietrich K, Wittnam JL, Rezaei-Ghaleh N, Pillot T, Papot-Couturier S, Lefebvre T, Sprenger F, Wirths O, Zweckstetter M, Bayer TA, Acta Neuropathol 2013 126 189 205 10.1007/s00401-013- 1129-2 23685882
24. Intraneuronal APP, not free A{beta} peptides in 3xTg-AD mice: implications for Tau versus Abeta-mediated Alzheimer neurodegeneration. Winton MJ, Lee EB, Sun E, Wong MM, Leight S, Zhang B, Trojanowski JQ, Lee VM, J Neurosci 2011 31 7691 7699 10.1523/JNEUROSCI.6637-10.2011 21613482
25. AbetaPP accumulation and/or intraneuronal amyloid-beta accumulation? The 3xTg-AD mouse model revisited. Wirths O, Dins A, Bayer TA, J Alzheimers Dis 2012 28 897 904 22112547
26. Amino-terminally truncated Abeta peptide species are the main component of cotton wool plaques. Miravalle L, Calero M, Takao M, Roher AE, Ghetti B, Vidal R, Biochemistry 2005 44 10810 10821 10.1021/bi0508237 16086583 (Pubitemid 41153641)
27. Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Miller DL, Papayannopoulos IA, Styles J, Bobin SA, Lin YY, Biemann K, Iqbal K, Arch Biochem Biophys 1993 301 41 52 10.1006/abbi.1993.1112 8442665 (Pubitemid 23227174)
28. Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer's disease. Portelius E, Bogdanovic N, Gustavsson MK, Volkmann I, Brinkmalm G, Zetterberg H, Winblad B, Blennow K, Acta Neuropathol 2010 120 185 193 10.1007/s00401-010-0690-1 20419305
29. Unusual phenotypic alteration of beta amyloid precursor protein (betaAPP) maturation by a new Val715Met betaAPP-770 mutation responsible for probable early-onset Alzheimer's disease. Ancolio K, Dumanchin C, Barelli H, Warter JM, Brice A, Campion D, Frebourg T, Checler F, Proc Natl Acad Sci U S A 1999 96 4119 4124 10.1073/pnas.96.7.4119 10097173 (Pubitemid 29169046)
30. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K, Proc Natl Acad Sci 1985 82 4245 4249 10.1073/pnas.82.12.4245 3159021 (Pubitemid 15053619)
31. Truncated beta-amyloid peptide species in pre-clinical Alzheimer's disease as new targets for the vaccination approach. Sergeant N, Bombois S, Ghestem A, Drobecq H, Kostanjevecki V, Missiaen C, Wattez A, David JP, Vanmechelen E, Sergheraert C, Delacourte A, J Neurochem 2003 85 1581 1591 10.1046/j.1471-4159.2003.01818.x 12787077 (Pubitemid 36702570)
32. On the seeding and oligomerization of pGlu-amyloid peptides (in vitro). Schilling S, Lauber T, Schaupp M, Manhart S, Scheel E, Bohm G, Demuth HU, Biochemistry 2006 45 12393 12399 10.1021/bi0612667 17029395 (Pubitemid 44583682)
33. Presenilin-1 mutations in Alzheimer's disease. Russo C, Schettini G, Saido TC, Hulette C, Lippa C, Lannfelt L, Ghetti B, Gambetti P, Tabaton M, Teller JK, Nature 2000 405 531 532 10.1038/35014735 10850703 (Pubitemid 30367716)
34. Amino-truncated amyloid beta-peptide (Abeta5-40/42) produced from caspase-cleaved amyloid precursor protein is deposited in Alzheimer's disease brain. Takeda K, Araki W, Akiyama H, Tabira T, Faseb J 2004 18 1755 1757 15364896 (Pubitemid 39561674)
35. Pyroglutamate amyloid β (Aβ) aggravates behavioral deficits in transgenic amyloid mouse model for Alzheimer disease. Wittnam JL, Portelius E, Zetterberg H, Gustavsson MK, Schilling S, Koch B, Demuth H-U, Blennow K, Wirths O, Bayer TA, J Biol Chem 2012 287 8154 8162 10.1074/jbc.M111.308601 22267726
36. The arctic AbetaPP mutation leads to Alzheimer's disease pathology with highly variable topographic deposition of differentially truncated Abeta. Kalimo H, Lalowski M, Bogdanovic N, Philipson O, Bird TD, Nochlin D, Schellenberg GD, Brundin R, Olofsson T, Soliymani R, Baumann M, Wirths O, Bayer TA, Nilsson LN, Basun H, Lannfelt L, Ingelsson M, Acta Neuropathol Commun 2013 1 60 10.1186/2051-5960-1-60 24252272
37. Intraneuronal beta-amyloid accumulation and synapse pathology in Alzheimer's disease. Gouras GK, Tampellini D, Takahashi RH, Capetillo-Zarate E, Acta Neuropathol 2010 119 523 541 10.1007/s00401-010-0679-9 20354705
38. A modified beta-amyloid hypothesis: intraneuronal accumulation of the beta-amyloid peptide-the first step of a fatal cascade. Wirths O, Multhaup G, Bayer TA, J Neurochem 2004 91 513 520 10.1111/j.1471-4159.2004.02737.x 15485483 (Pubitemid 39431147)
39. Intraneuronal Aβ accumulation and neurodegeneration: lessons from transgenic models. Wirths O, Bayer TA, Life sciences 2012 91 1148 1152 10.1016/j.lfs.2012.02.001 22401905
40. Intracellular accumulation of amyloid-beta-a predictor for synaptic dysfunction and neuron loss in Alzheimer's disease. Bayer TA, Wirths O, Front Aging Neurosci 2010 2 8 20552046
41. Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice. Wirths O, Multhaup G, Czech C, Blanchard V, Moussaoui S, Tremp G, Pradier L, Beyreuther K, Bayer TA, Neurosci Lett 2001 306 116 120 10.1016/S0304-3940(01)01876-6 11403971 (Pubitemid 32524311)
42. Intraneuronal APP/Abeta trafficking and plaque formation in beta-amyloid precursor protein and presenilin-1 transgenic mice. Wirths O, Multhaup G, Czech C, Feldmann N, Blanchard V, Tremp G, Beyreuther K, Pradier L, Bayer TA, Brain Pathol 2002 12 275 286 12146796 (Pubitemid 34743210)
43. Intraneuronal Alzheimer Abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Takahashi RH, Milner TA, Li F, Nam EE, Edgar MA, Yamaguchi H, Beal MF, Xu H, Greengard P, Gouras GK, Am J Pathol 2002 161 1869 1879 10.1016/S0002-9440(10)64463-X 12414533 (Pubitemid 35265544)
44. Intracellular Abeta and cognitive deficits precede beta-amyloid deposition in transgenic arcAbeta mice. Knobloch M, Konietzko U, Krebs DC, Nitsch RM, Neurobiol Aging 2007 28 1297 1306 10.1016/j.neurobiolaging.2006.06. 019 16876915 (Pubitemid 47081235)
45. The arctic Alzheimer mutation facilitates early intraneuronal Abeta aggregation and senile plaque formation in transgenic mice. Lord A, Kalimo H, Eckman C, Zhang XQ, Lannfelt L, Nilsson LN, Neurobiol Aging 2006 27 67 77 10.1016/j.neurobiolaging.2004.12.007 16298242 (Pubitemid 41627951)
46. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease. Van Broeck B, Vanhoutte G, Pirici D, Van Dam D, Wils H, Cuijt I, Vennekens K, Zabielski M, Michalik A, Theuns J, De Deyn PP, Van der Linden A, Van Broeckhoven C, Kumar-Singh S, Neurobiol Aging 2008 29 241 252 10.1016/j.neurobiolaging.2006.10.016 17112635
47. Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease. Schmitz C, Rutten BP, Pielen A, Schafer S, Wirths O, Tremp G, Czech C, Blanchard V, Multhaup G, Rezaie P, Korr H, Steinbusch HW, Pradier L, Bayer TA, Am J Pathol 2004 164 1495 1502 10.1016/S0002-9440(10)63235- X 15039236 (Pubitemid 38387814)
48. Intracellular Abeta triggers neuron loss in the cholinergic system of the APP/PS1KI mouse model of Alzheimer's disease. Christensen DZ, Bayer TA, Wirths O, Neurobiol Aging 2010 31 1153 1163 10.1016/j.neurobiolaging.2008.07.022 18771817
49. Transient intraneuronal Abeta rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice. Christensen DZ, Kraus SL, Flohr A, Cotel MC, Wirths O, Bayer TA, Acta Neuropathol 2008 116 647 655 10.1007/s00401-008-0451-6 18974993
50. Intraneuronal pyroglutamate-Abeta 3-42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model. Wirths O, Breyhan H, Cynis H, Schilling S, Demuth HU, Bayer TA, Acta Neuropathol 2009 118 487 496 10.1007/s00401-009-0557-5 19547991
51. N-truncated Abeta starting with position four: early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibody. Antonios G, Saiepour N, Bouter Y, Richard BC, Paetau A, Verkkoniemi-Ahola A, Lannfelt L, Ingelsson M, Kovacs GG, Pillot T, Wirths O, Bayer TA, Acta Neuropathol Commun 2013 1 56 10.1186/2051-5960-1-56 24252153
52. Mass spectrometry of purified amyloid beta protein in Alzheimer's disease. Mori H, Takio K, Ogawara M, Selkoe DJ, J Biol Chem 1992 267 17082 17086 1512246
53. Quantification of Alzheimer pathology in ageing and dementia: age-related accumulation of amyloid-β (42) peptide in vascular dementia. Lewis H, Beher D, Cookson N, Oakley A, Piggott M, Morris CM, Jaros E, Perry R, Ince P, Kenny RA, Ballard CG, Shearman MS, Kalaria RN, Neuropathol Appl Neurobiol 2006 32 103 118 10.1111/j.1365-2990.2006.00696.x 16599940
54. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain. Güntert A, Dobeli H, Bohrmann B, Neuroscience 2006 143 461 475 10.1016/j.neuroscience.2006.08.027 17008022 (Pubitemid 44716598)
55. Overlapping profiles of Abeta peptides in the Alzheimer's disease and pathological aging brains. Moore BD, Chakrabarty P, Levites Y, Kukar TL, Baine AM, Moroni T, Ladd TB, Das P, Dickson DW, Golde TE, Alzheimers Res Ther 2012 4 18 10.1186/alzrt121 22621179